<DOC>
	<DOCNO>NCT02091362</DOCNO>
	<brief_summary>The main purpose trial determine effect study drug know LY2409021 blood pressure pulse rate participant type 2 diabetes mellitus ( T2DM ) compare placebo . The study two period . Each participant receive LY2409021 placebo period . At least 4 week pas period . The study last 23 week participant . Participants may remain stable dose metformin , prescribe personal physician .</brief_summary>
	<brief_title>A Study LY2409021 Blood Pressure Pulse Rate Participants With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Have type 2 diabetes mellitus ( accord World Health Organization diagnostic criterion ) use diet exercise alone combination stable dose metformin ( &gt; /=1000 mg/day [ &lt; 1000 mg , document intolerance 1000 mg high dosage ] immediaterelease metformin extendedrelease metformin least 2 month screen ) . Have glycated hemoglobin ( HbA1c ) value &gt; /=6.5 % &lt; /=8.5 % , determined central laboratory screening . Have mean blood pressure &gt; 90/60 millimeter mercury ( mm Hg ) &lt; 140/90 mm Hg screening . If treat hypertension , take 3 few antihypertensive medication take stable dos medication least 1 month screening . Stable body weight ( ±5 % ) &gt; /=3 month screen . Body mass index &gt; /=20 kilograms/meters square ( kg/m² ) &lt; 40 kg/m² . In investigator 's opinion , well motivate , capable , willing : Reliably administer oral study drug daily ; Maintain study diary ; Perform selfmonitored blood glucose test ; Wear ambulatory blood pressure monitor device least 24 hour ( multiple occasion ) . Are woman childbearing potential due : Surgical sterilization , hysterectomy , bilateral oophorectomy ( least 6 week postsurgery ) tubal ligation ( confirmed medical history ) ; Menopause . Women intact uterus deem menopausal cessation menses least 1 year follicle stimulate hormone &gt; 40 milliinternational unit per milliliter ( mIU/mL ) , take hormone oral contraceptive within 1 year , otherwise healthy . Males sexually active and/or partner childbearing age must use reliable method birth control study 3 month last dos study medication . These requirement apply participant partner surgically sterilize menarche 1 year postmenopausal . Have severe gastrointestinal disease may significantly affect gastric empty motility . Previous history active diagnosis pancreatitis . Acute chronic hepatitis , sign symptoms liver disease , alanine aminotransferase ( ALT ) level great 2.5 time upper limit normal ( ULN ) . Elevated total bilirubin ( great 2 time ULN ) , clinically suspicious sign symptom cirrhosis history cirrhosis . Mean rest pulse rate ( PR ) less 60 beat per minute ( bpm ) great 100 bpm . Current diagnosis personal history neuroendocrine tumor , family history type multiple endocrine neoplasia , Von HippelLindau disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>